From July 1, 2022 to August 18, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 227,719 shares, representing 3.24% for KRW 3,718.7 million under the buyback announced on February 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,480 KRW | +1.05% |
|
+4.09% | +11.23% |
1st Jan change | Capi. | |
---|---|---|
+11.23% | 62.56M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+4.28% | 22.58B | |
-37.63% | 17.61B | |
-6.79% | 17.6B | |
-14.32% | 17.26B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- A049960 Stock
- News Cell Biotech Co., Ltd.
- Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.